EGF and carcinoma: The EGF-NIR, rapidly saturated the EGFR in a focal CRC set-up, and was able to detect with high sensitivity 15–30% of EGFR expressing cells in a heterogeneous mixture of carcinoma/enterocyte cells in vitro.